SeaStar Medical Reports 65.1% Survival Rate At Day 90 In Its QUELIMMUNE SAVE Registry Analysis Presented At ASN Kidney Week 2026
SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today
SeaStar Medical showed that 65 percent of very sick patients survived. This is data the company shared with doctors, so watch if they move forward with their treatment.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.